Kristian Hallundbæk Mikkelsen1, Filip Krag Knop1, Morten Frost1, Jesper Hallas1, Anton Pottegård1. 1. Center for Diabetes Research (K.H.M., F.K.K.), Gentofte Hospital, University of Copenhagen, Hellerup; Novo Nordisk Foundation Center for Basic Metabolic Research (K.H.M., F.K.K.), Department of Biomedical Sciences, University of Copenhagen, Denmark; Department of Medicine (M.F.), Kolding Hospital, Kolding, Denmark; Endocrine Research Unit (M.F.), University of Southern Denmark, Odense, Denmark; and Clinical Pharmacology (J.H., A.P.), Department of Public Health, University of Southern Denmark, Odense, Denmark.
Abstract
CONTEXT AND OBJECTIVE: Evidence that bacteria in the human gut may influence nutrient metabolism is accumulating. We investigated whether use of antibiotics influences the risk of developing type 2 diabetes and whether the effect can be attributed to specific types of antibiotics. METHODS: We conducted a population-based case-control study of incident type 2 diabetes cases in Denmark (population 5.6 million) between January 1, 2000, and December 31, 2012. Data from the Danish National Registry of Patients, the Danish National Prescription Registry, and the Danish Person Registry were combined. RESULTS: The odds ratio (OR) associating type 2 diabetes with exposure to antibiotics of any type was 1.53 (95% confidence interval 1.50-1.55) with redemption of more than or equal to 5 versus 0-1 prescriptions. Although no individual group of antibiotics was specifically associated with type 2 diabetes risk, slightly higher ORs for type 2 diabetes were seen with narrow-spectrum and bactericidal antibiotics (OR 1.55 and 1.48) compared to broad-spectrum and bacteriostatic types of antibiotics (OR 1.31 and 1.39), respectively. A clear dose-response effect was seen with increasing cumulative load of antibiotics. The increased use of antibiotics in patients with type 2 diabetes was found up to 15 years before diagnosis of type 2 diabetes as well as after the diagnosis. CONCLUSIONS: Our results could support the possibility that antibiotics exposure increases type 2 diabetes risk. However, the findings may also represent an increased demand for antibiotics from increased risk of infections in patients with yet-undiagnosed diabetes.
CONTEXT AND OBJECTIVE: Evidence that bacteria in the human gut may influence nutrient metabolism is accumulating. We investigated whether use of antibiotics influences the risk of developing type 2 diabetes and whether the effect can be attributed to specific types of antibiotics. METHODS: We conducted a population-based case-control study of incident type 2 diabetes cases in Denmark (population 5.6 million) between January 1, 2000, and December 31, 2012. Data from the Danish National Registry of Patients, the Danish National Prescription Registry, and the Danish Person Registry were combined. RESULTS: The odds ratio (OR) associating type 2 diabetes with exposure to antibiotics of any type was 1.53 (95% confidence interval 1.50-1.55) with redemption of more than or equal to 5 versus 0-1 prescriptions. Although no individual group of antibiotics was specifically associated with type 2 diabetes risk, slightly higher ORs for type 2 diabetes were seen with narrow-spectrum and bactericidal antibiotics (OR 1.55 and 1.48) compared to broad-spectrum and bacteriostatic types of antibiotics (OR 1.31 and 1.39), respectively. A clear dose-response effect was seen with increasing cumulative load of antibiotics. The increased use of antibiotics in patients with type 2 diabetes was found up to 15 years before diagnosis of type 2 diabetes as well as after the diagnosis. CONCLUSIONS: Our results could support the possibility that antibiotics exposure increases type 2 diabetes risk. However, the findings may also represent an increased demand for antibiotics from increased risk of infections in patients with yet-undiagnosed diabetes.
Authors: Anne Vrieze; Els Van Nood; Frits Holleman; Jarkko Salojärvi; Ruud S Kootte; Joep F W M Bartelsman; Geesje M Dallinga-Thie; Mariette T Ackermans; Mireille J Serlie; Raish Oozeer; Muriel Derrien; Anne Druesne; Johan E T Van Hylckama Vlieg; Vincent W Bloks; Albert K Groen; Hans G H J Heilig; Erwin G Zoetendal; Erik S Stroes; Willem M de Vos; Joost B L Hoekstra; Max Nieuwdorp Journal: Gastroenterology Date: 2012-06-20 Impact factor: 22.682
Authors: A Mor; K Berencsi; E Svensson; J Rungby; J S Nielsen; S Friborg; I Brandslund; J S Christiansen; A Vaag; H Beck-Nielsen; H T Sørensen; R W Thomsen Journal: Diabet Med Date: 2015-07-03 Impact factor: 4.359
Authors: Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon Journal: Proc Natl Acad Sci U S A Date: 2004-10-25 Impact factor: 11.205
Authors: Milford H Marchant; Nicholas A Viens; Chad Cook; Thomas Parker Vail; Michael P Bolognesi Journal: J Bone Joint Surg Am Date: 2009-07 Impact factor: 5.284
Authors: Vanessa K Ridaura; Jeremiah J Faith; Federico E Rey; Jiye Cheng; Alexis E Duncan; Andrew L Kau; Nicholas W Griffin; Vincent Lombard; Bernard Henrissat; James R Bain; Michael J Muehlbauer; Olga Ilkayeva; Clay F Semenkovich; Katsuhiko Funai; David K Hayashi; Barbara J Lyle; Margaret C Martini; Luke K Ursell; Jose C Clemente; William Van Treuren; William A Walters; Rob Knight; Christopher B Newgard; Andrew C Heath; Jeffrey I Gordon Journal: Science Date: 2013-09-06 Impact factor: 47.728
Authors: Ole Köhler-Forsberg; Liselotte Petersen; Christiane Gasse; Preben B Mortensen; Soren Dalsgaard; Robert H Yolken; Ole Mors; Michael E Benros Journal: JAMA Psychiatry Date: 2019-03-01 Impact factor: 21.596
Authors: Paula Roca-Saavedra; Veronica Mendez-Vilabrille; Jose Manuel Miranda; Carolina Nebot; Alejandra Cardelle-Cobas; Carlos M Franco; Alberto Cepeda Journal: J Physiol Biochem Date: 2017-05-09 Impact factor: 4.158
Authors: María Castro-Penalonga; Paula Roca-Saavedra; Jose Manuel Miranda; Jose Julio Porto-Arias; Carolina Nebot; Alejandra Cardelle-Cobas; Carlos Manuel Franco; Alberto Cepeda Journal: J Physiol Biochem Date: 2017-06-17 Impact factor: 4.158
Authors: Gregory L Kinney; Emma H Baker; Oana L Klein; Jennifer L Black-Shinn; Emily S Wan; Barry Make; Elizabeth Regan; Russell P Bowler; Sharon M Lutz; Kendra A Young; Lindsey M Duca; George R Washko; Edwin K Silverman; James D Crapo; John E Hokanson Journal: Chronic Obstr Pulm Dis Date: 2016